| immune system process (GO:0002376) | 2.29 | 4 | NBN, PRF1, SBDS, IFNG |
| cellular process (GO:0009987) | 0.26 | 4 | NBN, PRF1, SBDS, IFNG |
| single-organism cellular process (GO:0044763) | 0.65 | 4 | NBN, PRF1, IFNG, SBDS |
| single-organism process (GO:0044699) | 0.48 | 4 | NBN, PRF1, SBDS, IFNG |
| response to stimulus (GO:0050896) | 1.22 | 3 | NBN, PRF1, IFNG |
| cellular component organization (GO:0016043) | 1.24 | 3 | NBN, PRF1, SBDS |
| response to stress (GO:0006950) | 1.8 | 3 | NBN, PRF1, IFNG |
| cell cycle process (GO:0022402) | 2.75 | 3 | NBN, SBDS, IFNG |
| immune effector process (GO:0002252) | 3.58 | 3 | NBN, PRF1, IFNG |
| cellular component organization or biogenesis (GO:0071840) | 1.22 | 3 | NBN, PRF1, SBDS |
| regulation of phosphate metabolic process (GO:0019220) | 2.35 | 2 | NBN, IFNG |
| regulation of primary metabolic process (GO:0080090) | 1.08 | 2 | NBN, IFNG |
| regulation of metabolic process (GO:0019222) | 1.02 | 2 | NBN, IFNG |
| regulation of response to stimulus (GO:0048583) | 1.54 | 2 | NBN, IFNG |
| signal transduction (GO:0007165) | 1.28 | 2 | NBN, IFNG |
| cell chemotaxis (GO:0060326) | 4.63 | 2 | IFNG, SBDS |
| organic cyclic compound metabolic process (GO:1901360) | 1.26 | 2 | NBN, SBDS |
| cellular response to stimulus (GO:0051716) | 1.97 | 2 | NBN, IFNG |
| negative regulation of cell cycle (GO:0045786) | 3.67 | 2 | NBN, IFNG |
| positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 2 | NBN, IFNG |
| response to external biotic stimulus (GO:0043207) | 3.13 | 2 | PRF1, IFNG |
| regulation of signal transduction (GO:0009966) | 1.84 | 2 | NBN, IFNG |
| response to virus (GO:0009615) | 4.21 | 2 | PRF1, IFNG |
| regulation of cellular metabolic process (GO:0031323) | 1.07 | 2 | NBN, IFNG |
| cell activation involved in immune response (GO:0002263) | 4.86 | 2 | NBN, IFNG |
| interspecies interaction between organisms (GO:0044419) | 3.08 | 2 | PRF1, IFNG |
| positive regulation of molecular function (GO:0044093) | 2.23 | 2 | NBN, IFNG |
| positive regulation of biological process (GO:0048518) | 1.2 | 2 | NBN, IFNG |
| negative regulation of biological process (GO:0048519) | 1.33 | 2 | NBN, IFNG |
| system process (GO:0003008) | 2.3 | 2 | NBN, IFNG |
| leukocyte chemotaxis (GO:0030595) | 4.96 | 2 | IFNG, SBDS |
| positive regulation of DNA metabolic process (GO:0051054) | 4.49 | 2 | NBN, IFNG |
| chemotaxis (GO:0006935) | 4.04 | 2 | SBDS, IFNG |
| regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 2 | NBN, IFNG |
| lymphocyte activation (GO:0046649) | 3.96 | 2 | NBN, IFNG |
| response to other organism (GO:0051707) | 3.48 | 2 | PRF1, IFNG |
| multi-organism process (GO:0051704) | 2.65 | 2 | PRF1, IFNG |
| regulation of phosphorylation (GO:0042325) | 2.5 | 2 | NBN, IFNG |
| positive regulation of phosphorylation (GO:0042327) | 2.9 | 2 | NBN, IFNG |
| regulation of biological quality (GO:0065008) | 1.68 | 2 | NBN, IFNG |
| response to biotic stimulus (GO:0009607) | 3.09 | 2 | PRF1, IFNG |
| response to external stimulus (GO:0009605) | 2.55 | 2 | PRF1, IFNG |
| cell motility (GO:0048870) | 3.02 | 2 | IFNG, SBDS |
| cellular response to stress (GO:0033554) | 2.51 | 2 | NBN, IFNG |
| cellular component assembly (GO:0022607) | 2.14 | 2 | PRF1, SBDS |
| negative regulation of metabolic process (GO:0009892) | 1.93 | 2 | NBN, IFNG |
| positive regulation of metabolic process (GO:0009893) | 1.74 | 2 | NBN, IFNG |
| movement of cell or subcellular component (GO:0006928) | 2.61 | 2 | SBDS, IFNG |
| leukocyte activation (GO:0045321) | 3.76 | 2 | NBN, IFNG |
| nitrogen compound metabolic process (GO:0006807) | 1.13 | 2 | NBN, SBDS |
| regulation of biological process (GO:0050789) | 0.45 | 2 | NBN, IFNG |
| cellular macromolecule metabolic process (GO:0044260) | 0.93 | 2 | NBN, SBDS |
| lymphocyte activation involved in immune response (GO:0002285) | 5.22 | 2 | NBN, IFNG |
| heterocycle metabolic process (GO:0046483) | 1.31 | 2 | NBN, SBDS |
| macromolecular complex assembly (GO:0065003) | 2.55 | 2 | PRF1, SBDS |
| leukocyte activation involved in immune response (GO:0002366) | 4.88 | 2 | NBN, IFNG |
| biological regulation (GO:0065007) | 0.39 | 2 | NBN, IFNG |
| regulation of molecular function (GO:0065009) | 1.78 | 2 | NBN, IFNG |
| cell migration (GO:0016477) | 3.12 | 2 | IFNG, SBDS |
| positive regulation of cellular component organization (GO:0051130) | 2.68 | 2 | NBN, IFNG |
| regulation of catalytic activity (GO:0050790) | 1.97 | 2 | NBN, IFNG |
| transport (GO:0006810) | 1.51 | 2 | PRF1, IFNG |
| regulation of biosynthetic process (GO:0009889) | 1.37 | 2 | NBN, IFNG |
| regulation of cellular process (GO:0050794) | 0.5 | 2 | NBN, IFNG |
| defense response (GO:0006952) | 2.78 | 2 | PRF1, IFNG |
| programmed cell death (GO:0012501) | 3.1 | 2 | PRF1, IFNG |
| cell activation (GO:0001775) | 3.47 | 2 | NBN, IFNG |
| metabolic process (GO:0008152) | 0.58 | 2 | NBN, SBDS |
| immune response (GO:0006955) | 2.86 | 2 | PRF1, IFNG |
| negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 2 | NBN, IFNG |
| regulation of intracellular signal transduction (GO:1902531) | 2.31 | 2 | NBN, IFNG |
| cell cycle arrest (GO:0007050) | 4.69 | 2 | NBN, IFNG |
| defense response to virus (GO:0051607) | 4.63 | 2 | PRF1, IFNG |
| positive regulation of protein modification process (GO:0031401) | 2.7 | 2 | NBN, IFNG |
| regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 2 | NBN, IFNG |
| single-organism developmental process (GO:0044767) | 1.49 | 2 | NBN, SBDS |
| regulation of cellular component organization (GO:0051128) | 2.01 | 2 | NBN, IFNG |
| cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 2 | NBN, SBDS |
| regulation of signaling (GO:0023051) | 1.72 | 2 | NBN, IFNG |
| regulation of cell communication (GO:0010646) | 1.73 | 2 | NBN, IFNG |
| positive regulation of catalytic activity (GO:0043085) | 2.4 | 2 | NBN, IFNG |
| nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 2 | NBN, SBDS |
| establishment of localization (GO:0051234) | 1.48 | 2 | PRF1, IFNG |
| positive regulation of phosphorus metabolic process (GO:0010562) | 2.78 | 2 | NBN, IFNG |
| regulation of protein metabolic process (GO:0051246) | 1.93 | 2 | NBN, IFNG |
| positive regulation of protein metabolic process (GO:0051247) | 2.43 | 2 | NBN, IFNG |
| positive regulation of cellular protein metabolic process (GO:0032270) | 2.49 | 2 | NBN, IFNG |
| regulation of protein modification process (GO:0031399) | 2.32 | 2 | NBN, IFNG |
| developmental process (GO:0032502) | 1.36 | 2 | NBN, SBDS |
| organelle organization (GO:0006996) | 2.02 | 2 | NBN, SBDS |
| multicellular organismal process (GO:0032501) | 1.45 | 2 | NBN, IFNG |
| cell proliferation (GO:0008283) | 3.23 | 2 | NBN, SBDS |
| neurological system process (GO:0050877) | 2.64 | 2 | NBN, IFNG |
| cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 2 | NBN, SBDS |
| defense response to other organism (GO:0098542) | 3.75 | 2 | PRF1, IFNG |
| regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 2 | NBN, IFNG |
| macromolecule metabolic process (GO:0043170) | 0.83 | 2 | NBN, SBDS |
| anatomical structure development (GO:0048856) | 1.58 | 2 | NBN, SBDS |
| macromolecular complex subunit organization (GO:0043933) | 2.14 | 2 | PRF1, SBDS |
| regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 2 | NBN, IFNG |
| positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 2 | NBN, IFNG |
| negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 2 | NBN, IFNG |
| apoptotic signaling pathway (GO:0097190) | 4.12 | 2 | NBN, IFNG |
| mitotic cell cycle process (GO:1903047) | 3.12 | 2 | NBN, SBDS |
| nucleic acid metabolic process (GO:0090304) | 1.46 | 2 | NBN, SBDS |
| leukocyte migration (GO:0050900) | 4.19 | 2 | IFNG, SBDS |
| cell death (GO:0008219) | 3.05 | 2 | PRF1, IFNG |
| regulation of DNA metabolic process (GO:0051052) | 3.87 | 2 | NBN, IFNG |
| regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 2 | NBN, IFNG |
| organic substance metabolic process (GO:0071704) | 0.63 | 2 | NBN, SBDS |
| positive regulation of nucleobase-containing compound metabolic process (GO:0045935) | 2.35 | 2 | NBN, IFNG |
| negative regulation of nucleobase-containing compound metabolic process (GO:0045934) | 2.55 | 2 | NBN, IFNG |
| positive regulation of phosphate metabolic process (GO:0045937) | 2.78 | 2 | NBN, IFNG |
| regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 2 | NBN, IFNG |
| apoptotic process (GO:0006915) | 3.14 | 2 | PRF1, IFNG |
| regulation of phosphorus metabolic process (GO:0051174) | 2.35 | 2 | NBN, IFNG |
| multi-organism cellular process (GO:0044764) | 3.14 | 2 | PRF1, IFNG |
| regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 2 | NBN, IFNG |
| negative regulation of nitrogen compound metabolic process (GO:0051172) | 2.47 | 2 | NBN, IFNG |
| positive regulation of nitrogen compound metabolic process (GO:0051173) | 2.29 | 2 | NBN, IFNG |
| localization (GO:0051179) | 1.4 | 2 | PRF1, IFNG |
| locomotion (GO:0040011) | 2.91 | 2 | SBDS, IFNG |
| primary metabolic process (GO:0044238) | 0.69 | 2 | NBN, SBDS |
| regulation of cell cycle (GO:0051726) | 2.93 | 2 | NBN, IFNG |
| taxis (GO:0042330) | 4.03 | 2 | SBDS, IFNG |
| cellular metabolic process (GO:0044237) | 0.69 | 2 | NBN, SBDS |
| viral process (GO:0016032) | 3.15 | 2 | PRF1, IFNG |
| symbiosis, encompassing mutualism through parasitism (GO:0044403) | 3.15 | 2 | PRF1, IFNG |
| regulation of protein phosphorylation (GO:0001932) | 2.57 | 2 | NBN, IFNG |
| positive regulation of protein phosphorylation (GO:0001934) | 2.95 | 2 | NBN, IFNG |
| negative regulation of cellular process (GO:0048523) | 1.41 | 2 | NBN, IFNG |
| positive regulation of cellular process (GO:0048522) | 1.3 | 2 | NBN, IFNG |